Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Asumi Iesato"'
Autor:
Asumi Iesato, Carmelo Nucera
Publikováno v:
Molecules, Vol 26, Iss 10, p 3022 (2021)
Thyroid cancer (TC) is the most common endocrine malignancy. Most TCs have a favorable prognosis, whereas anaplastic thyroid carcinoma (ATC) is a lethal form of cancer. Different genetic and epigenetic alterations have been identified in aggressive f
Externí odkaz:
https://doaj.org/article/ce8e4e57e35140eda6f09eff494c11e2
Autor:
Asumi Iesato, Stephanie Li, Peter M. Sadow, Mohammadreza Abbasian, Ara Nazarian, Jack Lawler, Carmelo Nucera
Publikováno v:
Thyroid.
Publikováno v:
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 31:31-37
Autor:
Asumi Iesato, Carmen Priolo, Xiaowen Liu, Isaac E. Stillman, Suzanne D. Burke, Carmelo Nucera, Zsuzsanna K. Zsengellér, Alfredo Pontecorvi, Veronica Valvo, Taylor R. Kavanagh
Publikováno v:
Thyroid. 31:1335-1358
Background: BRAFV600E acts as an ATP-dependent cytosolic kinase. BRAFV600E inhibitors are widely available, but resistance to them is widely reported in the clinic. Lipid metabolism (fatty acids) i...
Autor:
Giovanni Roti, Stephanie Li, Michele R. Hacker, Carmelo Nucera, Andrew H. Fischer, Asumi Iesato
Publikováno v:
J Clin Endocrinol Metab
Context Pericyte populations abundantly express tyrosine kinases (eg, platelet-derived growth factor receptor-β [PDGFR-β]) and impact therapeutic response. Lenvatinib is a clinically available tyrosine kinase inhibitor that also targets PDGFR-β. D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0883c5df35041adb8b5a540fc98336ac
https://europepmc.org/articles/PMC8864753/
https://europepmc.org/articles/PMC8864753/
Autor:
Asumi Iesato, Mitsuo Terada, Atsushi Fushimi, Rie Tahara, Kanako Nishiyama, Madoka Iwase, Nami Yamashita
Publikováno v:
Annals of Oncology. 33:S492
Autor:
Veronica, Valvo, Asumi, Iesato, Taylor R, Kavanagh, Carmen, Priolo, Zsuzsanna, Zsengeller, Alfredo, Pontecorvi, Isaac E, Stillman, Suzanne D, Burke, Xiaowen, Liu, Carmelo, Nucera
Publikováno v:
Thyroid
Background: BRAF(V600E) acts as an ATP-dependent cytosolic kinase. BRAF(V600E) inhibitors are widely available, but resistance to them is widely reported in the clinic. Lipid metabolism (fatty acids) is fundamental for energy and to control cell stre
Publikováno v:
Oncotarget
// Asumi Iesato 1 , Teruo Nakamura 1 , Hiroto Izumi 2 , Takeshi Uehara 3 and Ken-Ichi Ito 1 1 Division of Breast, Endocrine and Respiratory Surgery, Department of Surgery (II), Shinshu University School of Medicine, Matsumoto, Japan 2 Department of O
Autor:
Asumi Iesato, Takaaki Oba, Mayu Ono, Ken-ichi Ito, Yasuhiro Mochizuki, Tokiko Ito, Kazuma Maeno, Akihiko Yoshizawa, Toshiharu Kanai, Fumiyoshi Takayama
Publikováno v:
The Breast Journal. 23:220-224
An adenomyoepithelioma of the breast is a rare tumor characterized by biphasic proliferation of both epithelial and myoepithelial cells. This tumor is generally considered as a benign neoplasm, and there are few reports describing the imaging feature
Autor:
Tatsunori, Chino, Takaaki, Oba, Kana, Yamamoto, Daiya, Takekoshi, Asumi, Iesato, Tokiko, Ito, Toshiharu, Kanai, Kazuma, Maeno, Kenichi, Ito
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 45(12)
A 61-year-old woman presented with metastatic breast cancer in her right lung 4 years and 11 months after the operation for her right breast cancer(HER2 enriched type). Chemotherapy(pertuzumab plus trastuzumab plus docetaxel)were ad- ministered. On d